# FDA Inspection 1302076 - InvaGen Pharmaceuticals, Inc. - February 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/6f49afaf-f928-4ba0-a5bc-1df3f32d761d
Source feed: FDA_Inspections

> FDA Inspection 1302076 for InvaGen Pharmaceuticals, Inc. on February 09, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302076
- Company Name: InvaGen Pharmaceuticals, Inc.
- Inspection Date: 2026-02-09
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1223321 - 2023-10-25](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/ab7f3625-f61f-420c-9396-b2e66e188b6d)
- [FDA Inspection 1111971 - 2019-12-06](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/c8e75b2a-217b-40b5-9c72-f760213ca045)
- [FDA Inspection 1053263 - 2018-05-25](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/e3d4a9c8-e980-4a32-9fdf-d26c6a11a868)
- [FDA Inspection 1007073 - 2017-03-30](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/dcaac525-f15c-4af7-b544-7f96f6648e7f)
- [FDA Inspection 970802 - 2016-04-20](https://www.keypedia.com/records/fda_inspections/invagen-pharmaceuticals-inc/8476f5de-f564-4bca-a923-100d7dbb3e57)

Company: https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/8841516b-25bb-463f-9666-11b69458c306

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d